Vol 5, Supplement 1 (June 2016): Translational Cancer Research

Editorial

The genetic heterogeneity of hepatocellular carcinoma and the implications for personalised medicine
Marco Y. W. Zaki, Helen L. Reeves
Allogeneic anti-CD19 CAR T cells: new perspectives in the treatment of B-cell malignancies that progress after allogeneic stem cell transplantation?
Maël Heiblig, Gilles Salles, Xavier Thomas
Gene therapy-based prophylaxis to rescue the “prima ballerina”
Francesco Bernardi, Mirko Pinotti
The role of nuclear factor-kappa B and endoplasmic reticulum stress in hepatitis B viral-induced hepatocellular carcinoma
Joe Yeong, Valerie Chew
Dual targeting of EGFR: ready for prime time?
Hui K. Gan, Antony W. Burgess, Adam C. Parslow, Andrew M. Scott
Expanding treatment options for metastatic gastric cancer
Giandomenico Roviello, Giulia Borsella, Daniele Generali
Moving molecular subtypes to the clinic in gastric cancer
Joseph Chao, Jeeyun Lee, Samuel J. Klempner
Clinical translation of predictive markers for anti-EGFR monoclonal antibody therapy in metastatic colorectal cancer
Andrew Rowland, Christos S. Karapetis, Arduino A. Mangoni, Michael D. Wiese, Ganessan Kichenadasse, Ross A. McKinnon, Michael J. Sorich
Taking action on actionable mutations: a French initiative on universality in precision cancer care
Michael Cabanero, Ming-Sound Tsao
Intraoperative subtyping of lung adenocarcinoma: an unmet need
Nurlan Aliyev, Yusuke Takahashi, Shaohua Lu, Marissa Mayor, Prasad S. Adusumilli
Is there really a role for the comprehensive geriatric assessment in metastatic non-small cell lung cancer?
Charlotte Leduc, Elisabeth Quoix
Screening for mutations in lung cancer in France: purpose of precision medicine
Anne-Marie Ruppert, Jacques Cadranel, Marie Wislez
Clinical significance of miR-15 and miR-16 in ovarian cancer
Heidi Schwarzenbach
Microtubule targeting agents in glioma
Anda-Alexandra Calinescu, Maria G. Castro
Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?
David Marc Davies, John Maher
Innate immunosurveillance: the next frontier in the cancer immunotherapy toolbox
Amy E. Gillgrass, Ali A. Ashkar

Commentary

Identification of molecular subtypes and significantly mutated genes in gastric cancer using next-generation sequencing
Byungho Lim, Seon-Young Kim
Biomarkers and stage II colorectal cancer therapy
Ritika Zijoo, Anthony J. Olszanski, David S. Weinberg
The role of Sym004, a novel EGFR antibody mixture, in patients with refractory colorectal cancer
Elena Fountzilas, George Pentheroudakis
Unearthing a novel tumor suppressor function of ATOH8 in hepatocellular carcinoma: role in acquisition of cancer stem cell-like features
Fung Zhao, Jun Yu
Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers
Guoli Chen, Ming-Tseh Lin
Can we effective use sym004 in tumours harboring EGFR extracellular domain mutations?
Mahmut Uçar, Veli Berk
MET exon 14 mutation: another actionable genomic variation in patients with advanced NSCLC
Massimo Di Maio, Paolo Bironzo, Giorgio Vittorio Scagliotti
Repurposing an HIV drug to improve efficacy of targeted therapy in melanoma
Lawrence W. Wu, Gao Zhang, Meenhard Herlyn
Commentary on the GEC-ESTRO trial: is partial breast irradiation ready for prime time?
Kazuhiko Sato
Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ—is the pain worth the gain?—a commentary on the NSABP-B35 trial
Kirsty E. Stuart, John Boyages
Concurrent or sequential letrozole with adjuvant breast radiotherapy
Icro Meattini, Giulio Francolini, Lorenzo Livi
Concurrent or sequential letrozole with adjuvant breast radiotherapy
Orit Kaidar-Person, Timothy M. Zagar
Fat lure: adipocytes attract cancer cells out of the prostate
Alexandra M. Blee, Haojie Huang
Surgical intervention and circulating tumor cell count: a commentary
Jocelyn R. Marshall, Michael R. King
Fat talks: a new role for adipose tissue in promoting prostate cancer in obesity
Matthew J. Watt, Renea A. Taylor
miR-15a and miR-16 supplementation as a potential remedy for ovarian cancer
P. Anoop Chandran, Sebastian Häusler, Jörg Wischhusen
Emerging roles in prolactin-mediated BRCA1 function
Da Li, Qi-Jun Wu
Epigenetics of cancer: the role of histone methyltransferase, SETDB1, in cancer metastasis
Jeng-Wei Lu, C. K. James Shen, Tsai-Yu Tzeng
A novel role for Cish in the inhibition of TCR signaling
Tara S. Abraham, Adam E. Snook
Role of c-MYC/miRNA-548/HDAC6 axis in drug resistance and lymphoma survival
Waseem Gul Lone, Jiayu Yu, Javeed Iqbal